Comprehensive Analysis of Potential Biomarkers of Acute Lymphoblastic Leukemia in Children by Using a Competing Endogenous RNA Network

Acute lymphoblastic leukemia (ALL) is the most serious hematological carcinoma in adolescents. The significance of long noncoding RNAs (lncRNAs) and their regulative role in the proliferation and differentiation of myeloid cells in cancer has been recently reported. Nevertheless, key RNAs and the re...

Full description

Saved in:
Bibliographic Details
Published inJournal of oncology Vol. 2022; pp. 1 - 15
Main Authors Lin, Xiao-Ying, Yuen, Ka-Yuk, Chen, Hai-Lei, Shen, Miao-Na, Huang, Yan, Huang, Qian-Wen, Liu, Yong, Xu, Lu-Hong
Format Journal Article
LanguageEnglish
Published Egypt Hindawi 06.04.2022
John Wiley & Sons, Inc
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Acute lymphoblastic leukemia (ALL) is the most serious hematological carcinoma in adolescents. The significance of long noncoding RNAs (lncRNAs) and their regulative role in the proliferation and differentiation of myeloid cells in cancer has been recently reported. Nevertheless, key RNAs and the regulatory mechanism of competitive endogenous RNA (ceRNA) network affected by pediatric ALL are not fully illustrated. In this study, phase 2 and 3 pediatric ALL RNA profiles were extracted from the TARGET database and used to identify lncRNAs, microRNAs, and messenger RNAs in high-risk ALL and reconstruct the sponge ceRNA regulatory network. Results indicated that 44 lncRNAs, 25 miRNAs, and 115 mRNA were up/downregulated. Functional analysis with differentially expressed RNAs (DERNAs) showed enriched significant signaling pathways, including PI3K-Akt and p53 signaling cascades and other pathways associated with the tumor. Seventeen differential hub RNAs, including LINC00909, BZRAP1-AS1, C17orf76-AS1, HCG11, MIAT, SNHG5, SNHG15, and TP73-AS1, were identified. The Cox model of correlation indicated that 14 of these RNAs were associated with the progression of pediatric ALL. These findings would help clarify the regulatory role of several lncRNAs as well as provide insights into the leukemogenesis of pediatric ALL to further explore novel prognostic markers/therapeutic targets for ALL.
AbstractList Acute lymphoblastic leukemia (ALL) is the most serious hematological carcinoma in adolescents. The significance of long noncoding RNAs (lncRNAs) and their regulative role in the proliferation and differentiation of myeloid cells in cancer has been recently reported. Nevertheless, key RNAs and the regulatory mechanism of competitive endogenous RNA (ceRNA) network affected by pediatric ALL are not fully illustrated. In this study, phase 2 and 3 pediatric ALL RNA profiles were extracted from the TARGET database and used to identify lncRNAs, microRNAs, and messenger RNAs in high-risk ALL and reconstruct the sponge ceRNA regulatory network. Results indicated that 44 lncRNAs, 25 miRNAs, and 115 mRNA were up/downregulated. Functional analysis with differentially expressed RNAs (DERNAs) showed enriched significant signaling pathways, including PI3K-Akt and p53 signaling cascades and other pathways associated with the tumor. Seventeen differential hub RNAs, including LINC00909, BZRAP1-AS1, C17orf76-AS1, HCG11, MIAT, SNHG5, SNHG15, and TP73-AS1, were identified. The Cox model of correlation indicated that 14 of these RNAs were associated with the progression of pediatric ALL. These findings would help clarify the regulatory role of several lncRNAs as well as provide insights into the leukemogenesis of pediatric ALL to further explore novel prognostic markers/therapeutic targets for ALL.
Acute lymphoblastic leukemia (ALL) is the most serious hematological carcinoma in adolescents. The significance of long noncoding RNAs (lncRNAs) and their regulative role in the proliferation and differentiation of myeloid cells in cancer has been recently reported. Nevertheless, key RNAs and the regulatory mechanism of competitive endogenous RNA (ceRNA) network affected by pediatric ALL are not fully illustrated. In this study, phase 2 and 3 pediatric ALL RNA profiles were extracted from the TARGET database and used to identify lncRNAs, microRNAs, and messenger RNAs in high-risk ALL and reconstruct the sponge ceRNA regulatory network. Results indicated that 44 lncRNAs, 25 miRNAs, and 115 mRNA were up/downregulated. Functional analysis with differentially expressed RNAs (DERNAs) showed enriched significant signaling pathways, including PI3K-Akt and p53 signaling cascades and other pathways associated with the tumor. Seventeen differential hub RNAs, including LINC00909, BZRAP1-AS1, C17orf76-AS1, HCG11, MIAT, SNHG5, SNHG15, and TP73-AS1, were identified. The Cox model of correlation indicated that 14 of these RNAs were associated with the progression of pediatric ALL. These findings would help clarify the regulatory role of several lncRNAs as well as provide insights into the leukemogenesis of pediatric ALL to further explore novel prognostic markers/therapeutic targets for ALL.Acute lymphoblastic leukemia (ALL) is the most serious hematological carcinoma in adolescents. The significance of long noncoding RNAs (lncRNAs) and their regulative role in the proliferation and differentiation of myeloid cells in cancer has been recently reported. Nevertheless, key RNAs and the regulatory mechanism of competitive endogenous RNA (ceRNA) network affected by pediatric ALL are not fully illustrated. In this study, phase 2 and 3 pediatric ALL RNA profiles were extracted from the TARGET database and used to identify lncRNAs, microRNAs, and messenger RNAs in high-risk ALL and reconstruct the sponge ceRNA regulatory network. Results indicated that 44 lncRNAs, 25 miRNAs, and 115 mRNA were up/downregulated. Functional analysis with differentially expressed RNAs (DERNAs) showed enriched significant signaling pathways, including PI3K-Akt and p53 signaling cascades and other pathways associated with the tumor. Seventeen differential hub RNAs, including LINC00909, BZRAP1-AS1, C17orf76-AS1, HCG11, MIAT, SNHG5, SNHG15, and TP73-AS1, were identified. The Cox model of correlation indicated that 14 of these RNAs were associated with the progression of pediatric ALL. These findings would help clarify the regulatory role of several lncRNAs as well as provide insights into the leukemogenesis of pediatric ALL to further explore novel prognostic markers/therapeutic targets for ALL.
Audience Academic
Author Xu, Lu-Hong
Lin, Xiao-Ying
Huang, Yan
Chen, Hai-Lei
Shen, Miao-Na
Liu, Yong
Yuen, Ka-Yuk
Huang, Qian-Wen
AuthorAffiliation 3 Department of Pediatrics, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, China
1 Hematologic Laboratory of Pediatrics, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, China
2 Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, China
AuthorAffiliation_xml – name: 1 Hematologic Laboratory of Pediatrics, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, China
– name: 2 Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, China
– name: 3 Department of Pediatrics, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, China
Author_xml – sequence: 1
  givenname: Xiao-Ying
  surname: Lin
  fullname: Lin, Xiao-Ying
  organization: Hematologic Laboratory of PediatricsSun Yat-sen Memorial HospitalSun Yat-sen UniversityGuangzhou 510120Chinasysu.edu.cn
– sequence: 2
  givenname: Ka-Yuk
  surname: Yuen
  fullname: Yuen, Ka-Yuk
  organization: Hematologic Laboratory of PediatricsSun Yat-sen Memorial HospitalSun Yat-sen UniversityGuangzhou 510120Chinasysu.edu.cn
– sequence: 3
  givenname: Hai-Lei
  surname: Chen
  fullname: Chen, Hai-Lei
  organization: Hematologic Laboratory of PediatricsSun Yat-sen Memorial HospitalSun Yat-sen UniversityGuangzhou 510120Chinasysu.edu.cn
– sequence: 4
  givenname: Miao-Na
  surname: Shen
  fullname: Shen, Miao-Na
  organization: Hematologic Laboratory of PediatricsSun Yat-sen Memorial HospitalSun Yat-sen UniversityGuangzhou 510120Chinasysu.edu.cn
– sequence: 5
  givenname: Yan
  surname: Huang
  fullname: Huang, Yan
  organization: Hematologic Laboratory of PediatricsSun Yat-sen Memorial HospitalSun Yat-sen UniversityGuangzhou 510120Chinasysu.edu.cn
– sequence: 6
  givenname: Qian-Wen
  surname: Huang
  fullname: Huang, Qian-Wen
  organization: Hematologic Laboratory of PediatricsSun Yat-sen Memorial HospitalSun Yat-sen UniversityGuangzhou 510120Chinasysu.edu.cn
– sequence: 7
  givenname: Yong
  orcidid: 0000-0002-8324-3635
  surname: Liu
  fullname: Liu, Yong
  organization: Hematologic Laboratory of PediatricsSun Yat-sen Memorial HospitalSun Yat-sen UniversityGuangzhou 510120Chinasysu.edu.cn
– sequence: 8
  givenname: Lu-Hong
  orcidid: 0000-0002-3695-6990
  surname: Xu
  fullname: Xu, Lu-Hong
  organization: Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene RegulationSun Yat-sen Memorial HospitalSun Yat-sen UniversityGuangzhou 510120Chinasysu.edu.cn
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35432537$$D View this record in MEDLINE/PubMed
BookMark eNp9kktv1DAUhS1URNuBHWtkiQ0SDHX8SrJBCqPykEYFIbq2nOR6xh3HHuyk1fwBfjdJZyilEqx8ZX8-5x77nqIjHzwg9Dwjb7NMiDNKKD3jQjJB2SN0kskinxdckKN79TE6TemKEMlJKZ-gYyY4o4LlJ-jnInTbCGvwyV4Drrx2u2QTDgZ_DT343mqH39vQ6biBeLtfNUMPeLnrtutQO5162-AlDBvorMbW48XaujaCx_UOXybrV1jjyQX6qT73bViBD0PC3y4qfAH9TYibp-ix0S7Bs8M6Q5cfzr8vPs2XXz5-XlTLecNz2c85lbI0kJd13UrBSA5FWxSSM05LWeZ1a5ipua45AM9KwRowBSvazEjDNKkZm6F3e93tUHfQNmPAqJ3aRjsG3Kmgrfr7xNu1WoVrVRKSSy5HgVcHgRh-DJB61dnUgHPaw5hJUSkoYZxIOqIvH6BXYYjjA99SGc9ozss_1Eo7UNabMPo2k6iq8smUkDHIDL243_ddw78_cgTe7IEmhpQimDskI2qaEzXNiTrMyYjTB3hje93bMKW27l-XXu8vra1v9Y39v8UvP-XMlw
CitedBy_id crossref_primary_10_3389_fonc_2023_1108564
crossref_primary_10_3390_ijms251810210
Cites_doi 10.2147/OTT.S223321
10.1007/s00011-020-01345-x
10.1016/j.biopha.2018.10.046
10.1016/j.ccell.2016.05.007
10.1056/NEJMra052603
10.1080/15384101.2017.1407893
10.1002/jgm.3074
10.1186/s13045-016-0344-4
10.1002/jcb.26231
10.1089/dna.2016.3533
10.1016/j.canlet.2019.04.030
10.1186/s12943-017-0692-x
10.1038/s41419-019-1479-3
10.2139/ssrn.3844927
10.1016/j.biopha.2019.108965
10.3324/haematol.2018.199364
10.3892/or.2016.5147
10.1177/0963689719887370
10.1016/j.leukres.2019.106265
10.1038/bcj.2017.53
10.3390/ijms20020412
10.1080/21691401.2019.1608221
10.1002/jcp.27393
10.3389/fphar.2016.00491
10.1186/s12967-019-1882-7
10.1002/jcb.27918
10.1056/NEJMra1400972
10.3389/fgene.2021.656042
10.1038/leu.2013.226
10.1038/onc.2014.131
ContentType Journal Article
Copyright Copyright © 2022 Xiao-Ying Lin et al.
COPYRIGHT 2022 John Wiley & Sons, Inc.
Copyright © 2022 Xiao-Ying Lin et al. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright © 2022 Xiao-Ying Lin et al. 2022
Copyright_xml – notice: Copyright © 2022 Xiao-Ying Lin et al.
– notice: COPYRIGHT 2022 John Wiley & Sons, Inc.
– notice: Copyright © 2022 Xiao-Ying Lin et al. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: Copyright © 2022 Xiao-Ying Lin et al. 2022
DBID RHU
RHW
RHX
AAYXX
CITATION
NPM
3V.
7RV
7X7
7XB
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
KB0
M0S
NAPCQ
PHGZM
PHGZT
PIMPY
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOI 10.1155/2022/4563523
DatabaseName Hindawi Publishing Complete
Hindawi Publishing Subscription Journals
Hindawi Publishing Open Access
CrossRef
PubMed
ProQuest Central (Corporate)
Nursing & Allied Health Database
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
ProQuest Health & Medical Collection
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest Central (New)
ProQuest One Academic Eastern Edition
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
CrossRef

PubMed
Publicly Available Content Database
Database_xml – sequence: 1
  dbid: RHX
  name: Hindawi Publishing Open Access
  url: http://www.hindawi.com/journals/
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1687-8450
Editor Zhong, Wei long
Editor_xml – sequence: 1
  givenname: Wei long
  surname: Zhong
  fullname: Zhong, Wei long
EndPage 15
ExternalDocumentID PMC9007646
A700760095
35432537
10_1155_2022_4563523
Genre Journal Article
GrantInformation_xml – fundername: Guangdong Basic and Applied Basic Research Foundation
  grantid: 2020A1515010312
GroupedDBID ---
188
29L
2WC
4.4
53G
5GY
5VS
7RV
7X7
8FI
8FJ
AAFWJ
AAJEY
AAWTL
ABDBF
ABUWG
ADBBV
ADRAZ
AFKRA
AINHJ
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
BENPR
CCPQU
DIK
E3Z
EBD
EBS
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IEA
IHR
IHW
INH
INR
ITC
KQ8
M48
NAPCQ
O5R
OK1
PIMPY
RHU
RHW
RHX
RPM
TR2
TUS
UKHRP
~8M
0R~
24P
AAYXX
ACCMX
ALIPV
CITATION
H13
OVT
PGMZT
PHGZM
PHGZT
2UF
ACUHS
CEFSP
CNMHZ
EJD
IL9
NPM
O5S
UZ5
3V.
7XB
8FK
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
AZQEC
DWQXO
K9.
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c476t-42669fe79bbd65307e8d88643429697bdf3fb4ab4ee41953cef838d1f6f3a0b33
IEDL.DBID M48
ISSN 1687-8450
IngestDate Thu Aug 21 18:30:25 EDT 2025
Fri Jul 11 12:01:12 EDT 2025
Fri Jul 25 10:13:54 EDT 2025
Tue Jun 17 22:02:33 EDT 2025
Wed Feb 19 02:25:41 EST 2025
Tue Jul 01 03:12:22 EDT 2025
Thu Apr 24 23:12:13 EDT 2025
Sun Jun 02 18:52:24 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Language English
License This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
https://creativecommons.org/licenses/by/4.0
Copyright © 2022 Xiao-Ying Lin et al.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c476t-42669fe79bbd65307e8d88643429697bdf3fb4ab4ee41953cef838d1f6f3a0b33
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Academic Editor: Wei long Zhong
ORCID 0000-0002-3695-6990
0000-0002-8324-3635
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1155/2022/4563523
PMID 35432537
PQID 2651412749
PQPubID 4727241
PageCount 15
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_9007646
proquest_miscellaneous_2652034062
proquest_journals_2651412749
gale_infotracmisc_A700760095
pubmed_primary_35432537
crossref_primary_10_1155_2022_4563523
crossref_citationtrail_10_1155_2022_4563523
hindawi_primary_10_1155_2022_4563523
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2022-04-06
PublicationDateYYYYMMDD 2022-04-06
PublicationDate_xml – month: 04
  year: 2022
  text: 2022-04-06
  day: 06
PublicationDecade 2020
PublicationPlace Egypt
PublicationPlace_xml – name: Egypt
– name: New York
PublicationTitle Journal of oncology
PublicationTitleAlternate J Oncol
PublicationYear 2022
Publisher Hindawi
John Wiley & Sons, Inc
Publisher_xml – name: Hindawi
– name: John Wiley & Sons, Inc
References 22
23
24
26
27
28
29
30
31
10
11
12
13
14
15
16
17
18
19
J. Zi (25) 2017; 7
1
2
3
4
5
6
7
8
9
20
21
References_xml – ident: 26
  doi: 10.2147/OTT.S223321
– ident: 29
  doi: 10.1007/s00011-020-01345-x
– ident: 6
  doi: 10.1016/j.biopha.2018.10.046
– ident: 8
  doi: 10.1016/j.ccell.2016.05.007
– ident: 3
  doi: 10.1056/NEJMra052603
– ident: 15
  doi: 10.1080/15384101.2017.1407893
– ident: 30
  doi: 10.1002/jgm.3074
– ident: 22
  doi: 10.1186/s13045-016-0344-4
– ident: 27
  doi: 10.1002/jcb.26231
– ident: 13
  doi: 10.1089/dna.2016.3533
– ident: 24
  doi: 10.1016/j.canlet.2019.04.030
– ident: 4
  doi: 10.1186/s12943-017-0692-x
– ident: 14
  doi: 10.1038/s41419-019-1479-3
– ident: 16
  doi: 10.2139/ssrn.3844927
– ident: 31
  doi: 10.1016/j.biopha.2019.108965
– ident: 20
  doi: 10.3324/haematol.2018.199364
– ident: 5
  doi: 10.3892/or.2016.5147
– ident: 10
  doi: 10.1177/0963689719887370
– ident: 28
  doi: 10.1016/j.leukres.2019.106265
– ident: 2
  doi: 10.1038/bcj.2017.53
– ident: 21
  doi: 10.3390/ijms20020412
– ident: 11
  doi: 10.1080/21691401.2019.1608221
– ident: 12
  doi: 10.1002/jcp.27393
– ident: 19
  doi: 10.3389/fphar.2016.00491
– volume: 7
  start-page: 869
  issue: 4
  year: 2017
  ident: 25
  article-title: Treatment with the C-C chemokine receptor type 5 (CCR5)-inhibitor maraviroc suppresses growth and induces apoptosis of acute lymphoblastic leukemia cells
  publication-title: American Journal of Cancer Research
– ident: 17
  doi: 10.1186/s12967-019-1882-7
– ident: 9
  doi: 10.1002/jcb.27918
– ident: 1
  doi: 10.1056/NEJMra1400972
– ident: 18
  doi: 10.3389/fgene.2021.656042
– ident: 23
  doi: 10.1038/leu.2013.226
– ident: 7
  doi: 10.1038/onc.2014.131
SSID ssj0064096
Score 2.2847002
Snippet Acute lymphoblastic leukemia (ALL) is the most serious hematological carcinoma in adolescents. The significance of long noncoding RNAs (lncRNAs) and their...
SourceID pubmedcentral
proquest
gale
pubmed
crossref
hindawi
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1
SubjectTerms Acute lymphocytic leukemia
Analysis
Apoptosis
Cancer therapies
Cell growth
Genes
Leukemia
Medical prognosis
MicroRNA
Pediatrics
Survival analysis
Tumor proteins
SummonAdditionalLinks – databaseName: Hindawi Publishing Open Access
  dbid: RHX
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3da9RAEB9sQfFF_Da2lRXqkwQv2Y9sHs-j5ZD2ELFwb2F3s-GCNpFrDuk_4N_dmWRz9KqiT_ma_SCzk_kN89sJwHHGnXaqtLGV0saCsofGWxFrbXUljDGJpd3I5ws1vxCflnIZiiRd_Z7CR29H4Xn6Af08QgW-B3u4wCgony_HD67CEKXfRKTQXrSQk5HffqftjucJ39_7K4p8f9Z_wpd3aZK3_M7pY3gUACObDhp-Avd88xQenIeU-DP4RRa99quBiM7GIiOsrdjntiMuELb-WLeXxMNZ9_enbtN5dnaNimwtomfsmZ35zTd_WRtWN2wWNngze816SgEzbNbjazo_acp2qOzKviymbDHwyJ_DxenJ19k8Dj9XiJ3IVBeTZ84rn-XWlkqipXtdao34BB2UyjNbVryywljhvaBUm_OV5rpMKlVxM7Gcv4D9pm38K2CZxzBIY0ODupYODzKxia8w-BXcuUkE78cXX7hQeZx-gPG96CMQKQtSUxHUFMG7rfSPoeLGX-QOSYcFGSL25tAsXDHNhlRjLiM4Drr9Vy-j4otgvVdFqhBGJhiv5xG83T6mAYiR1nh8wySTTjjCoTSCl8M62Q7EpeCp5FkE2c4K2gpQTe_dJ0296mt75zR_oV7_3-wP4CFd9kwidQj73XrjjxAkdfZNbyI3QnIJOQ
  priority: 102
  providerName: Hindawi Publishing
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1La9wwEBZtSksvoe-6SYsK6amYrK2nT2G7JISSLKU0sDdjyRJr0tjJxkvIH-jvzowtu93Sx8nGlmRbo9F84_k0ImRPMautLE1shDAxx-hh4QyPtTba86IoEoOrkU_n8viMf16IRfjhdh1olcOc2E3UZWPxH_l-KsG0J-BDZQeXVzHuGoXR1bCFxn3yAFOXIaVLLUaHS4Lv0q0ukqBImovJQHwXAn3-dB_AA-APtmGSwsT8cIku8U31J-D5O3_yF4N09IRsByRJp73on5J7rn5GHp2GWPlz8gNVfeWWPUOdDtlHaOPpl6ZFkhDU_lQ1F0jQWXXXp3bdOnpyCxJuDMBqaJmeuPW5u6gKWtV0FlZ-U3NLO64BLeisA954fliXTZ_ylX6dT-m8J5i_IGdHh99mx3HYdSG2XMk2RpOdeacyY0opYApwutQagAtYLpkpU3rmDS8Md45jDM46r5kuEy89KyaGsZdkq25q95pQ5cA_0lCxgEEgLBxEYhLnwSvmzNpJRD4OHZ_bkJIcd8b4nneuiRA5iikPYorIh7H0ZZ-K4y_ldlGGOWootGZBX2w-VX0MMhMR2Quy_V8rg-DzoNbX-c9BGJH34218AFLVagc9jGXSCQOclEbkVT9OxgcxwVkqmIqI2hhBYwFM9r15p66WXdLvDN-fyzf_fq0d8hg_oqMWyV2y1a7W7i2gpta861TjDueQE4U
  priority: 102
  providerName: ProQuest
Title Comprehensive Analysis of Potential Biomarkers of Acute Lymphoblastic Leukemia in Children by Using a Competing Endogenous RNA Network
URI https://dx.doi.org/10.1155/2022/4563523
https://www.ncbi.nlm.nih.gov/pubmed/35432537
https://www.proquest.com/docview/2651412749
https://www.proquest.com/docview/2652034062
https://pubmed.ncbi.nlm.nih.gov/PMC9007646
Volume 2022
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3di9NAEB_uA8UX8fOMnmWF80miTfczDyK90rPItRzFg76F7GZDi3eJ1hbtP-Df7Uw-ij1O9CVNmt1N2JnJ_Ib57SzAiebOOJXZ0EppQ0HZw9RbERpjTS7SNI0srUYeT9ToUnyaydketLuNNhP4_dbQjvaTulxevf35bfMBDf59ZfBSUvzee4dAALEE34dD9EmaTHQstvkEhVFMtc5IoUkZIbstBf5G7x3n1Hyi78wpOP6xuA2C3mRS_uGazh7A_QZTsn6tBA9hzxeP4O64yZo_hl9k9Es_r7nqrK1DwsqcXZQrogth79NFeU1UnWX1f9-tV56db1DWpUWAjSOzc7_-4q8XKVsUbNCsAWd2wyrWAUvZoILgdD4ssrIu_sqmkz6b1FTzJ3B5Nvw8GIXN_guhE1qtQnLece51bG2mJH4MvMmMQQiDPkzF2mY5z61IrfBeUDbO-dxwk0W5ynnatZw_hYOiLPwzYNpjpGSwY4rqIB3-yMhGPsf4WHDnugG8aSc-cU1xctoj4yqpghQpExJT0ogpgNfb1l_rohx_aXdMMkxIe3A0h5bjkr6us5GxDOCkke2_RmkFn7T6mfQUIs0IQ_o4gFfb2_QAIq0VHmeY2vS6HBFTL4CjWk-2D-JS8J7kOgC9o0HbBlT2e_dOsZhX5b9jen-hnv_f27-Ae3RZkY3UMRyslmv_EnHUynZgX890Bw5Ph5OLKV59nEWdymzwOB3NfgNJGhs0
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Zb9NAEB5VqTheEDeGAovUPiGriffw-gGhNKRKaRJVVSv1zXjXayWitds0UZU_wM_hNzLjIxDE8dQnW_Ye9s7sHDvfzgJsh9xqq1LjGymNLyh6mDgjfK2NzkSSJB1Du5FHYzU4FZ_P5NkGfG_2whCsspGJpaBOC0tr5LuBQtXeQR8q-nh55dOpURRdbY7QqNji0C1v0GW7_nDwCem7EwT7_ZPewK9PFfCtCNXcJ5UUZS6MjEmVRBZ3OtUaFTNKZhWFJs14ZkRihHOCYkzWZZrrtJOpjCdtQwugKPI3BUdXpgWbe_3x0XEj-xV6S-V-JoVTVwvZbqD2UtIqQ7CL5gpaPHxNCdaq4M6EnPCb6Z9M3d8Rm7-owP2H8KC2XVm3YrZHsOHyx3B3VEfnn8A3Ei4zN6kw8azJd8KKjB0Vc4IlYe29aXFBkKBZ-bxrF3PHhkvkqcKgIY8ts6FbfHUX04RNc9ar95ozs2QluoElrFea-nTfz9OiSjLLjsddNq4g7U_h9FYo8gxaeZG7F8BChx6ZxooJsp20eJEd03EZ-uGCW9v24H0z8LGtk6DTWRzncekMSRkTmeKaTB7srEpfVsk__lJui2gYk0zA1izOUBt3wyrqGUkPtmva_q-VhvBxLUiu459s78G71WvqgMBxucMRpjJBm6NlFnjwvOKTVUdcCh5IHnoQrnHQqgClF19_k08nZZrxiL5fqJf__qy3cG9wMhrGw4Px4Su4Tz9UApvUFrTms4V7jTbb3LypJwqDL7c9N38ArVlR3A
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLamISZeEPeFDTDS9oSiNvElzgNCpVu1sa6aEJP6FmLHViNYsnWtpv4BfhS_jnNygyIuT3tKlDh2knP3-XxMyF7EjDIy074WQvscs4ep1dxXSivH0zQNNK5GPp3Io3P-YSqmG-R7uxYGYZWtTqwUdVYanCPvhRJMewAxVNxzDSzi7GD07vLKxx2kMNPabqdRs8iJXd1A-Hb99vgAaL0fhqPDT8Mjv9lhwDc8kgsfzVPsbBRrnUkB7G5VphQYadDSMo505pjTPNXcWo75JmOdYioLnHQs7WucDAX1fydiIkAZi6ZdsCchbqpWNkkQYsVFvwXdC4HzDWEPHBfwfdiaOWyMwt0ZhuM3-Z-c3t-xm78Yw9EDcr_xYumgZruHZMMWj8jWaZOnf0y-oZqZ21mNjqdt5RNaOnpWLhCgBE-_z8sLBAfNq-sDs1xYOl4Bd5UaXHromY7t8ou9yFOaF3TYrDqnekUrnANN6bBy-vH8sMjKutws_TgZ0EkNbn9Czm-FHk_JZlEWdpvQyEJspuDBFBhQGDiIQAfWQUTOmTF9j7xpf3ximnLouCvH16QKi4RIkExJQyaP7HetL-syIH9pt4s0TFA7QG8GZNUkg6jOf8bCI3sNbf_XS0v4pFEp18lPAfDI6-42DoAwucLCH8Y2YZ-BjxZ65FnNJ91ATHAWChZ5JFrjoK4BFhpfv1Pks6rgeIzvz-Xzf7_WK7IFEpmMjycnO-Qefk-FcJK7ZHMxX9oX4Lwt9MtKSij5fNti-QPGtlSs
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Comprehensive+Analysis+of+Potential+Biomarkers+of+Acute+Lymphoblastic+Leukemia+in+Children+by+Using+a+Competing+Endogenous+RNA+Network&rft.jtitle=Journal+of+oncology&rft.au=Lin%2C+Xiao-Ying&rft.au=Yuen%2C+Ka-Yuk&rft.au=Chen%2C+Hai-Lei&rft.au=Shen%2C+Miao-Na&rft.date=2022-04-06&rft.pub=Hindawi&rft.issn=1687-8450&rft.eissn=1687-8450&rft.volume=2022&rft_id=info:doi/10.1155%2F2022%2F4563523&rft.externalDocID=10_1155_2022_4563523
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1687-8450&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1687-8450&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1687-8450&client=summon